Global Biosimilars WeekGlobal Biosimilars Week

  • About
  • Basics
  • Approvals
  • Benefits
  • Experience
  • Future
  • Social Media
  • Resources

Global Biosimilars Week

MENU

Press Enter To Begin Your Search

Biosimilars: A Safe & Effective Option for Patients

In the U.S., the FDA is approving more biosimilars and patients are benefitting from these new medicines. Access to these safe, effective treatments offers patients improved health outcomes.

ORGANIZATION:

RESOURCE TYPE:
FACTSHEETS

OPEN
Skills

Factsheets

0

Biosimilars: Breaking Down Barriers to Patient Access (REMS)

Factsheets

Key figures on biosimilar medicines (2016)

Infographics

CONTACT US
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA - Rue de Cornavin 11 - 1201 Geneva, Switzerland - Telephone: +32 (0)2 5346607 (S. Kox)
E-mails: info@igbamedicines.org / skox@igbamedicines.org (Secretary General)
© 2020 International Generic and Biosimilar Medicines Association (IGBA), All Rights Reserved. For more information, contact IGBA